Current stock page

Stock Analysis

Innoviva, Inc. (INVA) Stock Analysis

Innoviva, Inc. (INVA) stock analysis covering valuation, fundamentals, technical indicators, risk, AIQ Momentum, analyst catalysts, dividends, and the current AIQ Score.

INVA Stock Analysis Summary

Innoviva, Inc. (INVA) currently has an AIQ Score of 67/100, indicating a bullish setup. Value is the strongest factor at 92/100. Momentum is the weakest current factor at 43/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data

INVA at a Glance

Crawlable current metrics from the latest market-close stock snapshot.

MetricCurrent
Price$19.03
AIQ Score67/100
Overall ViewBullish
Technical Analysis ConsensusStrong Sell
Market Cap$1.37B
P/E Ratio (TTM)7.49
Forward P/E—
EPS (Q3 FY2026)-$1.03
Revenue (Q3 FY2026)$106.12M
Dividend Yield (TTM)0.00%
Beta0.31
Volume560.91K
52-week range$18.66-$25.15
RSI 1433.12
50-Day SMA$20.70
200-Day SMA$21.89
Analyst Price Target—
Next EarningsFeb 24, 2027
As of Nov 13, 2026 · Market close

INVAInnoviva, Inc.

Healthcare / Biotechnology

Leader

Strong Relative Position

BullishEdge 8/10
$19.03+$0.06 (+0.32%)

Latest quote

  • Momentum
    43
  • Value
    92
  • Quality
    76
  • Risk resilience
    74
  • Sentiment
    —
algovestiq.comScore data as of Nov 13, 2026

INVA Stock Analysis Summary

Innoviva, Inc. (INVA) currently has an AIQ Score of 67/100, indicating a bullish setup. Value is the strongest factor at 92/100. Momentum is the weakest current factor at 43/100. Technical, fundamental, catalyst, dividend, and risk evidence should be read together at the latest market-close snapshot.

Updated Nov 13, 2026 · Market-close data
AIQ Composite Posture: Bullish

In a bullish regime, INVA has AIQ Score of 67/100 with Value base of 92/100 and fading Momentum at 43/100. Wait for component alignment before adding exposure.

Signal Conflict Detected

Value (92/100) leads while Momentum (43/100) lags. This cross-factor spread creates entry timing uncertainty.

Healthcare · 0.32% stock move · INVA classified in Biotechnology.

Current Evidence

BullishINVA is in a bullish AIQ regime; Value is the strongest visible factor at 92/100.
Core coverage reflects visible evidence only

AlgovestIQ Evidence Summary

Current consensus, supporting evidence, recent changes, and what would strengthen or weaken the view.

Is INVA Bullish or Bearish Right Now?

INVA currently has a bullish overall setup. Value is the strongest factor at 92/100, while Momentum is weakest at 43/100. The current evidence suggests a constructive setup.

Bull Case
  • - Quality is supportive at 76/100.
  • - Risk Resilience is supportive at 74/100.
Bear Case
  • - Momentum is weak at 43/100.
  • - Price is -13.06% below its 200-day SMA.
  • - Technical consensus has more sell votes than buy votes (36 vs 8).

Current Consensus

INVA's Technical Analysis Consensus is currently Strong Sell, with 8 buy, 2 neutral, and 36 sell votes. INVA's 14-day RSI is 33.12, which places the stock in a weaker momentum range. INVA's beta is 0.31, indicating lower market sensitivity than the broad market.

Signal Confidence
High agreement

What Changed in INVA?

The largest recent change in INVA is Momentum moving down by 5.0 points over the available 7-day comparison window. Value remains the strongest visible factor.

AIQ Score
-1.0
Momentum
-5.0
Quality
+0.0
Risk
+0.0

What Would Change the INVA Outlook?

The current bullish outlook could improve if AIQ reaches 65 (Bullish), momentum recovers, earnings revisions strengthen, and price confirms a stronger trend above the 50-day and 200-day moving averages. It would weaken if AIQ falls below 50 (Bearish), price loses long-term moving-average support, analyst expectations deteriorate, or risk evidence worsens.

Bullish confirmation

AIQ 65+ (Bullish), RSI above 55, price above SMA-50/SMA-200, and positive catalyst or estimate-revision evidence.

Bearish deterioration

AIQ below 50 (Bearish), RSI below 45, loss of SMA-200, negative revisions, or rising volatility and drawdown risk.

INVA Decision Framework

Public evidence layers, setup checks, and risk context for Innoviva, Inc..

Innoviva, Inc. (INVA) Stock Analysis

Innoviva, Inc. has an AIQ Score of 67/100 in a Bullish regime. Value is strongest at 92/100. Beta is 0.31, below market sensitivity. Review the supporting stock factors together before drawing a conclusion from any single score.

Evidence LayerPublic Evidence
Regime ContextINVA is in a Bullish AIQ regime with score 67/100.
Signal ConflictThe primary conflict is that value leads at 92/100 while momentum lags at 43/100.
Factor EvidenceMomentum 43/100 · Value 92/100 · Quality 76/100 · Risk 74/100
PersistenceCurrent snapshot evidence is shown; historical persistence remains in AIQ Pro.

Current Setup Checklist

Factor strengthPass

Value is the strongest factor at 92/100.

TimingFail

Momentum is 43/100 and RSI (14) is 33.1.

Regime fitPass

INVA is in a Bullish regime at 67/100.

Risk controlPass

Risk factor is 74/100 with beta 0.31 and annual volatility 25.21%.

ConflictWait

Current conflict: value leads at 92/100 while momentum lags at 43/100.

AIQ Score
67/100
Price
$19.03
Beta
0.31
RSI (14)
33.1

INVA Research Cluster

Ticker-specific paths for valuation, technical analysis, catalysts, dividends, financials, risk, and news.

INVA Fundamentals

INVA valuation, profitability, growth, margins, balance-sheet strength, and free cash flow.

Revenue
$106.12M
Net income
-$73.89M
Free cash flow
$41.67M
View full INVA fundamental analysis

INVA Technical Analysis

INVA technical setup based on RSI, MACD, moving averages, AIQ Momentum, volume, trend, volatility, and pivots.

Technical Analysis Consensus
Strong Sell
RSI 14
33.12
Price vs SMA-50
-8.07%
View full INVA technical analysis

INVA Stock Catalysts

Track INVA earnings, analyst ratings, price targets, estimate revisions, stock news, and upcoming events.

Next earnings
Feb 24, 2027
Analyst target
—
News items
1
View INVA earnings and stock catalysts

INVA Dividend Analysis

INVA dividend yield, annual dividend, payout ratio, payment history, and income reliability context.

Dividend yield
3.94%
Annual dividend
$0.75
Payout ratio
—
View INVA dividend history and analysis

INVA Financial Data

INVA revenue, earnings, income statement, balance sheet, cash flow, valuation ratios, and stock metrics.

Quarter revenue
$106.12M
EPS
-$1.03
Periods
8
View INVA financials

INVA Risk Analysis

INVA volatility, beta, drawdown, Sharpe ratio, VaR, and downside resilience.

Beta
0.31
Risk score
74/100
1Y volatility
25.21%
View INVA risk analysis

INVA Stock News

INVA stock news, market tone, recent headlines, and catalyst context.

News items
1
Updated
Nov 15, 2026
Sentiment
—
Read INVA stock news

INVA vs Biotechnology Peers

Current peer cohort: INVA · IRON · JAZZ · KOD · KRYS. Compare AIQ, factor scores, Sharpe ratio and 1-year volatility in one indexable view.

PeerAIQValueMomentumRiskSharpe1Y VolatilityCompare
INVA
Current stock
67/10092/10043/10074/100-0.6425.21%Current
IRON
Disc Medicine, Inc.
65/100—75/10051/1000.163.55%INVA vs IRON
JAZZ
Jazz Pharmaceuticals plc
73/10079/10066/10073/1001.4738.64%INVA vs JAZZ
KOD
Kodiak Sciences Inc.
52/100—91/10044/1001.43205.61%INVA vs KOD
KRYS
Krystal Biotech, Inc.
69/10067/10058/10069/1001.1639.38%INVA vs KRYS
Pairwise Compare links: IRON · JAZZ · KOD · KRYSINVA vs IRONINVA vs JAZZINVA vs KODINVA vs KRYSCompare cohort

Peer cohort is resolved dynamically from the AlgovestIQ universe taxonomy and Compare relationship graph. Data as of Nov 13, 2026.

About the AIQ Score

Methodology for the current stock evidence.

As of Nov 13, 2026 · Market close

The AlgovestIQ AIQ Score combines multiple dimensions of stock evidence, including momentum, valuation exposure, quality, risk resilience, sentiment context, and timing signals. It is a descriptive research score, not a guarantee of future performance or a personalized recommendation.

View AIQ methodology

Factor Diagnostics

A compact bridge from the AIQ score to the evidence tabs.

Calculator
Calculate a INVA stock return scenario

Open the return calculator with stock context while purchase price, shares, dates and fees remain user inputs.

Calculate stock return

Also for INVA: historical return with reinvested dividends and stock average calculator for several buys.

AIQ Component Profile

Compare the five component scores on one consistent 0–100 scale.

Catalyst preview

Review earnings timing, revisions, news pressure, and prior event reactions in one place.

Open catalysts
Quarterly evidence

8 recent quarterly periods are available for review.

Checked Nov 16, 2026

AIQ Pro

Explore factor drivers, conflicts, persistence, and scenario sensitivity in the advanced workspace.

Fundamentals Verdict

Current snapshot fields are separate from reported-quarter statement tables.

Current TTM P/E
7.49
As of Nov 13, 2026
Revenue growth
-1.56%
Gross margin
73.90%
Current debt / equity
0.24
Latest quarterly evidence

Latest period Sep 30, 2026.

Review fundamentals
Quarter revenue
$106.12M
Quarter net income
-$73.89M
Quarter free cash flow
$41.67M

Market Confirmation

Technicals are summarized first, with the indicator library behind it.

Trend
Bearish
Momentum
Bearish
RSI 14
33.12
MACD
-0.54

Risk Alignment

Higher resilience is stronger; exposure metrics stay separate.

Resilience
74/100
Beta
0.31
Annual volatility
25.21%
Max drawdown
-22.19%

INVA Stock FAQ

What is INVA stock price today?

Innoviva, Inc.'s current stock price is $19.03. Use the live quote with AIQ Score, news, and risk context rather than treating price alone as a decision signal.

Is INVA bullish or bearish right now?

INVA's bullish or bearish read depends on the current AIQ Score, factor alignment, technical analysis consensus, valuation, risk, and catalyst evidence. A mixed setup should be treated differently from a broad confirmation across those signals.

What is INVA's market cap?

INVA's market cap is $1.37B based on the latest completed market-close snapshot from Nov 13, 2026. Use it with P/E ratio, revenue, and growth metrics to frame company size, valuation, and peer comparisons.

What is INVA's current P/E ratio?

INVA's current P/E ratio is 7.49 based on the latest completed market-close snapshot from Nov 13, 2026. Read it with revenue growth, margins, EPS, cash flow, and peer valuation rather than using P/E alone.

What is INVA's RSI?

INVA's 14-day RSI is 33.12 based on the latest completed market-close snapshot from Nov 13, 2026. RSI should be interpreted with MACD, moving averages, volume, volatility, and price trend.

Is INVA above its 50-day and 200-day moving averages?

INVA is -8.07% from its 50-day SMA and -13.06% from its 200-day SMA based on the latest completed market-close snapshot from Nov 13, 2026. Moving-average position should be read with momentum and broader AIQ evidence.

When is INVA's next earnings date?

INVA's next earnings date is currently listed as Feb 24, 2027. Earnings can reset revenue, EPS, price target, analyst rating, and catalyst expectations.

Does INVA pay a dividend?

INVA's dividend yield is 0.00% based on the latest completed market-close snapshot from Nov 13, 2026. Dividend yield should be read with payout ratio, free cash flow, growth, and balance-sheet strength.